Genentech rejects Roche’s $43.7B bid

August 14, 2008

The biotechnology company Genentech, as expected, turned down a buyout offer Wednesday from its majority owner Roche, saying the bid of $89 a share was far too low. But in a statement, a special committee of Genentech’s board said it would consider a higher offer, which some analysts....

Read complete article